Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia.
作者： D. L. Nyenhuis , P. B. Gorelick , S. Freels , D. C. Garron
DOI: 10.1212/WNL.58.1.56
关键词:
摘要: To the Editor: I read with interest article by Nyenhuis et al.1 on progression of vascular dementia (VaD) versus neurodegenerative Alzheimer type. The authors state that examining effects treatments demented subjects receive, and areas brain affected ischemia, was beyond scope their article. However, if readers have some general information about these factors, they can more appropriately generalize reported results. Slowing course decline has been a focus research therapies. Currently, white patients AD may …
sci-hub.se 参考文章(33)
Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. American Journal of Psychiatry. ,vol. 153, pp. 1438- 1443 ,(1996) , 10.1176/AJP.153.11.1438
P B Gorelick, Y Harris, I Bempong, P Samuels, Why African Americans may not be participating in clinical trials. Journal of The National Medical Association. ,vol. 88, pp. 630- 634 ,(1996)
C. K. Liu, B. L. Miller, J. L. Cummings, C. M. Mehringer, M. A. Goldberg, S. L. Howng, D. F. Benson, A quantitative MRI study of vascular dementia Neurology. ,vol. 42, pp. 138- 138 ,(1992) , 10.1212/WNL.42.1.138
Daniel M. Sosin, Head Injury-Associated Deaths in the United States From 1979 to 1986 JAMA: The Journal of the American Medical Association. ,vol. 262, pp. 2251- 2255 ,(1989) , 10.1001/JAMA.1989.03430160073033
Kelvin O. Lim, Maj Hedehus, Michael Moseley, Alexander de Crespigny, Edith V. Sullivan, Adolf Pfefferbaum, Compromised White Matter Tract Integrity in Schizophrenia Inferred From Diffusion Tensor Imaging Archives of General Psychiatry. ,vol. 56, pp. 367- 374 ,(1999) , 10.1001/ARCHPSYC.56.4.367
H. C. Chui, J. I. Victoroff, D. Margolin, W. Jagust, R. Shankle, R. Katzman, Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers Neurology. ,vol. 42, pp. 473- 473 ,(1992) , 10.1212/WNL.42.3.473
Philip B. Gorelick, Risk Factors for Dementia Associated With Multiple Cerebral Infarcts: A Case-Control Analysis in Predominantly African-American Hospital-Based Patients JAMA Neurology. ,vol. 50, pp. 714- 720 ,(1993) , 10.1001/ARCHNEUR.1993.00540070034011
Philip B Gorelick, Sue Leurgans, DeJuran Richardson, Yvonne Harris, Merryl Billingsley, AAASPS Investigators, None, African American antiplatelet stroke prevention study: Clinical trial design Journal of Stroke & Cerebrovascular Diseases. ,vol. 7, pp. 426- 434 ,(1998) , 10.1016/S1052-3057(98)80127-4
J. J. Locascio, J. H. Growdon, S. Corkin, Cognitive test performance in detecting, staging, and tracking Alzheimer's disease JAMA Neurology. ,vol. 52, pp. 1087- 1099 ,(1995) , 10.1001/ARCHNEUR.1995.00540350081020
J. A. Mortimer, B. Ebbitt, S.-P. Jun, M. D. Finch, Predictors of cognitive and functional progression in patients with probable Alzheimer's disease Neurology. ,vol. 42, pp. 1689- 1689 ,(1992) , 10.1212/WNL.42.9.1689